Frazier Healthcare Ventures Makes Promotions
Frazier Healthcare Ventures has made four promotions within its growth equity team: Brian Morfitt and David Kosloff to principal and Steven Tallman and Joseph Whitters to operating partners. PRESS...
View ArticleClik here to view.
Achaogen Raises $65 Million
Achaogen, a San Francisco-based developer of antibiotics to treat life-threatening, multi-drug resistant bacterial infections, has raised $65 million in Series C funding. Frazier Healthcare Ventures...
View ArticleIncline Therapeutics Raises $43 Million, Signs Acquisition Option
Incline Therapeutics Inc., a hospital-focused specialty pharma startup, has raised $43 million in Series A funding. Frazier Healthcare Ventures led the round, and was joined by 5AM Ventures, Technology...
View ArticleConfirmed: Chimerix’s $45 Million Fundraising
As peHUB.com reported late last week, Chimerix Inc., the pharmaceutical drug company working on orally-available antiviral therapeutics has completed a $45 million fundraising. New investors include...
View ArticleClik here to view.
From the Filings…
(Recent funding news based on Form D filings with the S.E.C.) E-commerce platform provider Rearden Commerce has raised $46.98 million in a new round of financing, according to a filing with the S.E.C....
View ArticleTobira Therapeutics Names Andrew Hindman As President and Chief Executive
Tobira Therapeutics Inc. hired Andrew Hindman as president and chief executive officer. Hindman was Nodality Inc.’s senior vice president of corporate development.Tobira is a N.J.-based...
View ArticleClik here to view.
peHUB First Read
Burger King: Cashing in on lazy fat-arses No Experience Necessary! HuffPo’s latest hire Ouch: Backer calls Kickstarter “worst project ever” Stop Snitchin’! FBI bags more in insider trading probes Time...
View ArticlePowerVision Completes Funding Round
PowerVision, a private company developing an accommodating intraocular lens, had added Johnson & Johnson Development Corporation to its list of investors in a recent closing of its Series C...
View ArticleCollegium Pharmaceutical Raises $22.5M
Collegium Pharmaceutical Inc., a specialty pharmaceutical company focused on treatments for chronic pain, has raised $22.5 million in Series B financing. Longitude Capital and Skyline Ventures led the...
View ArticleTobira Therapeutics Appoints Three Execs
Tobira Therapeutics, a developer of innovative antiretroviral therapies for HIV, has appointed three executives in the finance, clinical and pharmaceutical sciences functions. Caroline Loewy joins the...
View ArticleClovis Oncology Raises $145 Million
Clovis Oncology, a developer of anti-cancer agents based in Boulder, Colo., secured $145 million in financing from Domain Associates, New Enterprise Associates (NEA), Versant Ventures, Aberdare...
View ArticleFrazier Healthcare Ventures Makes Promotions
Frazier Healthcare Ventures has made four promotions within its growth equity team: Brian Morfitt and David Kosloff to principal and Steven Tallman and Joseph Whitters to operating partners. PRESS...
View ArticleClik here to view.
Achaogen Raises $65 Million
Achaogen, a San Francisco-based developer of antibiotics to treat life-threatening, multi-drug resistant bacterial infections, has raised $65 million in Series C funding. Frazier Healthcare Ventures...
View ArticleIncline Therapeutics Raises $43 Million, Signs Acquisition Option
Incline Therapeutics Inc., a hospital-focused specialty pharma startup, has raised $43 million in Series A funding. Frazier Healthcare Ventures led the round, and was joined by 5AM Ventures, Technology...
View ArticleConfirmed: Chimerix’s $45 Million Fundraising
As peHUB.com reported late last week, Chimerix Inc., the pharmaceutical drug company working on orally-available antiviral therapeutics has completed a $45 million fundraising. New investors include...
View ArticleClik here to view.
From the Filings…
(Recent funding news based on Form D filings with the S.E.C.) E-commerce platform provider Rearden Commerce has raised $46.98 million in a new round of financing, according to a filing with the S.E.C....
View ArticleTobira Therapeutics Names Andrew Hindman As President and Chief Executive
Tobira Therapeutics Inc. hired Andrew Hindman as president and chief executive officer. Hindman was Nodality Inc.’s senior vice president of corporate development.Tobira is a N.J.-based...
View ArticleClik here to view.
peHUB First Read
Burger King: Cashing in on lazy fat-arses No Experience Necessary! HuffPo’s latest hire Ouch: Backer calls Kickstarter “worst project ever” Stop Snitchin’! FBI bags more in insider trading probes Time...
View ArticlePowerVision Completes Funding Round
PowerVision, a private company developing an accommodating intraocular lens, had added Johnson & Johnson Development Corporation to its list of investors in a recent closing of its Series C...
View ArticleCollegium Pharmaceutical Raises $22.5M
Collegium Pharmaceutical Inc., a specialty pharmaceutical company focused on treatments for chronic pain, has raised $22.5 million in Series B financing. Longitude Capital and Skyline Ventures led the...
View Article
